![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/disease_related_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/homo_sapiens_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/mus_musculus_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/danio_rerio_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/drosophila_melanogast_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/caenorhabditis_elegan_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/arabidopsis_thaliana_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/escherichia_coli_1.png)
Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YKL220C | FRE2 | SGDID:S000001703 | fre fadI flrD fsrC ubiB b3844 JW3820 |
NAD(P)H-flavin reductase (EC 1.5.1.41) (FMN reductase) (Ferrisiderophore reductase C) (NAD(P)H:flavin oxidoreductase) (Riboflavin reductase [NAD(P)H]) |
1.5.1.41 | Escherichia coli | 1qfj_d | P0AEN1 | 99.60 | 2.40E-19 | 2.10E-23 | 177.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YKL220C | FRE2 | SGDID:S000001703 | CYB5R3 DIA1 |
NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) (Fragment) |
1.6.2.2 | Sus scrofa | 3w2i_a | P83686 | 99.50 | 4.00E-18 | 3.40E-22 | 173.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | TM_1639 |
Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit homolog (Dihydroorotate oxidase B, electron transfer subunit homolog) |
Thermotoga maritima | 4ylf_a | Q9X1X4 | 99.40 | 1.70E-17 | 1.50E-21 | 169.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | YHB1 SCY_2125 |
YHB1 SCY_2125 |
1.14.12.17 | Saccharomyces cerevisiae | 4g1v_a | A6ZUP2 | 99.30 | 8.30E-17 | 7.20E-21 | 172.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | mmoC MCA1200 |
Methane monooxygenase component C (EC 1.14.13.25) (Methane hydroxylase) (Methane monooxygenase reductase) (MMOR) |
1.14.13.25 | Methylococcus capsulatus | 1tvc_a | P22868 | 99.50 | 4.50E-19 | 3.90E-23 | 178.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | LA_4327 |
LA_4327 |
Leptospira interrogans | 2rc5_a | Q8EY89 | 99.40 | 3.40E-17 | 2.80E-21 | 171.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | CYBB NOX2 |
Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) |
Homo sapiens | X-Linked Recessive Disease,Vascular Disease,Retinitis Pigmentosa,Alzheimer Disease,Primary Ciliary Dyskinesia,Ectodermal Dysplasia,Suppurative Lymphadenitis,Diastolic Heart Failure,Splenic Abscess,Alcoholic Cardiomyopathy,X-Linked Mendelian Susceptibility To Mycobacterial Diseases,Ehrlichiosis,Substance Abuse,Renal Hypertension,Cardiomyopathy, Familial Hypertrophic, 2,Atypical Mycobacteriosis, Familial,Phagocyte Bactericidal Dysfunction,Leukocyte Adhesion Deficiency, Type I,Gastrointestinal Tularemia,Chronic Granulomatous Disease,Disease Of Mental Health,Granulomatous Disease, Chronic, Autosomal Recessive, 4,Granulomatous Disease, Chronic, Autosomal Recessive, 1,Human Granulocytic Anaplasmosis,Immunodeficiency 34,Tuberculous Salpingitis,Immunodeficiency 27b,Malaria,Immune Deficiency Disease,X-Linked Monogenic Disease,Peripheral Artery Disease,Hypertension, Essential,Granulomatous Disease, Chronic, X-Linked,Lung Abscess |
3a1f_a | P04839 | ENSG00000165168 | CYBB | 98.70 | 4.80E-12 | 4.20E-16 | 119.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YKL220C | FRE2 | SGDID:S000001703 | hmp fhp PHG200 |
Flavohemoprotein (FHP) (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17) |
1.14.12.17 | Cupriavidus necator | 1cqx_a | P39662 | 99.40 | 1.90E-17 | 1.60E-21 | 177.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | ATR2 AR2 At4g30210 F9N11.60 |
NADPH--cytochrome P450 reductase 2 (CPR 2) (P450R 2) (EC 1.6.2.4) |
1.6.2.4 | Arabidopsis thaliana | 5gxu_a | Q9SUM3 | 98.90 | 4.00E-13 | 3.30E-17 | 153.20 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | AHA_2992 |
AHA_2992 |
Aeromonas hydrophila | 6k2l_a | A0KMJ5 | 99.30 | 7.80E-17 | 6.50E-21 | 164.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | NIA1 |
Nitrate reductase [NADH] (NR) (EC 1.7.1.1) (Fragment) |
1.7.1.1 | Zea mays | 1cnf_a | P17571 | 99.40 | 1.60E-17 | 1.30E-21 | 169.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Ferredoxin--NADP(+) reductase (EC 1.18.1.2) (Fragment) |
Ferredoxin--NADP(+) reductase (EC 1.18.1.2) (Fragment) |
1.18.1.2 | Zea mays | 3lo8_a | Q41736 | 99.60 | 1.70E-19 | 1.40E-23 | 188.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Cylst_1289 |
Cylst_1289 |
Cylindrospermum stagnale | 5o0t_a | K9WT99 | 99.60 | 2.10E-19 | 1.70E-23 | 177.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | ophA1 |
Phthalate dioxygenase reductase (PDR) (EC 1.-.-.-) |
Burkholderia cepacia | 2pia_a | P33164 | 99.50 | 1.10E-18 | 9.50E-23 | 182.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | hmp VC_A0183 |
Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17) |
1.14.12.17 | Vibrio cholerae | 4eh1_b | Q9KMY3 | 99.40 | 5.40E-18 | 4.70E-22 | 168.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | NIA |
Nitrate reductase [NADH] (NR) (EC 1.7.1.1) |
1.7.1.1 | Ulva prolifera | 5yly_a | A0A286R227 | 99.50 | 3.80E-18 | 3.20E-22 | 176.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | POR CYPOR |
NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4) |
1.6.2.4 | Homo sapiens | Steroid Inherited Metabolic Disorder,Myopathy, Centronuclear, 4,Classic Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency,Disorder Of Sexual Development,Kohler'S Disease,Familial Glucocorticoid Deficiency,Synostosis,Cortisone Reductase Deficiency,Radioulnar Synostosis,Craniosynostosis,Cytochrome P450 Oxidoreductase Deficiency,Premature Menopause,Amenorrhea,Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency,46,Xy Sex Reversal,Corneal Dystrophy, Posterior Polymorphous, 1,Crouzon Syndrome,Adrenal Insufficiency, Congenital, With 46,Xy Sex Reversal, Partial Or Complete,Asperger Syndrome,Antley-Bixler Syndrome,Odontochondrodysplasia,Persistent Mullerian Duct Syndrome,Humeroradial Synostosis,Lipoid Congenital Adrenal Hyperplasia,Antley-Bixler Syndrome With Genital Anomalies And Disordered Steroidogenesis,Antley-Bixler Syndrome Without Genital Anomalies Or Disordered Steroidogenesis |
3qft_a | P16435 | ENSG00000127948 | POR | 99.10 | 8.70E-15 | 7.10E-19 | 160.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YKL220C | FRE2 | SGDID:S000001703 | b5R |
b5R |
1.6.2.2 | Physarum polycephalum | 2eix_b | Q1HA49 | 99.50 | 4.90E-19 | 4.30E-23 | 176.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | PF3D7_0623200 |
Ferredoxin--NADP reductase, apicoplast (EC 1.18.1.2) |
1.18.1.2 | Plasmodium falciparum | 3jqp_d | C6KT68 | 99.40 | 1.30E-17 | 1.10E-21 | 174.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Nos1 Bnos |
Nitric oxide synthase, brain (EC 1.14.13.39) (BNOS) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) |
1.14.13.39 | Rattus norvegicus | 1f20_a | P29476 | 98.90 | 2.50E-13 | 2.10E-17 | 147.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | pyrK pyrZ LL1347 L183563 |
Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit (Dihydroorotate oxidase B, electron transfer subunit) |
Lactococcus lactis | 5ksw_d | Q9CFW7 | 99.40 | 9.00E-18 | 7.80E-22 | 169.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | ascD AMETH_3833 |
ascD AMETH_3833 |
Amycolatopsis methanolica | 5ogx_a | A0A076MZ01 | 99.70 | 3.20E-21 | 2.70E-25 | 203.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | PETH |
Ferredoxin--NADP reductase, leaf isozyme, chloroplastic (FNR) (EC 1.18.1.2) |
1.18.1.2 | Pisum sativum | 1qfy_a | P10933 | 99.60 | 1.20E-19 | 1.00E-23 | 189.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | tmoF |
Toluene-4-monooxygenase system, ferredoxin--NAD(+) reductase component (T4MO) (EC 1.18.1.3) (Ferredoxin--NAD(+) reductase) (Toluene-4-monooxygenase systme, electron transfer component) |
1.18.1.3 | Pseudomonas mendocina | 4wqm_a | Q03304 | 99.60 | 7.90E-20 | 6.70E-24 | 191.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | nqrF VC_2290 |
Na(+)-translocating NADH-quinone reductase subunit F (Na(+)-NQR subunit F) (Na(+)-translocating NQR subunit F) (EC 7.2.1.1) (NQR complex subunit F) (NQR-1 subunit F) |
7.2.1.1 | Vibrio cholerae | 4p6v_f | Q9X4Q8 | 99.60 | 2.00E-20 | 1.60E-24 | 203.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | 100282643 ZEAMMB73_Zm00001d011833 |
100282643 ZEAMMB73_Zm00001d011833 |
1.18.1.2 | Zea mays | 3vo2_b | B4FUM2 | 99.50 | 1.20E-18 | 9.70E-23 | 182.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | hmp fsrB hmpA b2552 JW2536 |
Flavohemoprotein (Flavohemoglobin) (HMP) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17) |
1.14.12.17 | Escherichia coli | 1gvh_a | P24232 | 99.40 | 8.70E-18 | 7.50E-22 | 180.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YKL220C | FRE2 | SGDID:S000001703 | fpr XAC1458 |
fpr XAC1458 |
1.18.1.2 | Xanthomonas axonopodis | 4b4d_a | Q8PMH0 | 99.50 | 2.30E-18 | 2.00E-22 | 174.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | benC ACIAD1438 |
Benzoate 1,2-dioxygenase electron transfer component [Includes: Ferredoxin; Ferredoxin--NAD(+) reductase (EC 1.18.1.3)] |
1.18.1.3 | Acinetobacter baylyi | 1krh_b | P07771 | 99.70 | 3.30E-21 | 2.90E-25 | 203.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | pyrK llmg_1105 |
Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit (Dihydroorotate oxidase B, electron transfer subunit) |
Lactococcus lactis | 1ep3_b | P56968 | 99.50 | 4.10E-18 | 3.50E-22 | 172.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | MTRR |
Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) |
1.16.1.8 | Homo sapiens | Ventricular Septal Defect,Heart Disease,Physical Disorder,Vascular Disease,Amino Acid Metabolic Disorder,Homocystinuria,Nondisjunction,Methylmalonic Acidemia Without Homocystinuria,Cleft Lip,Fallopian Tube Disease,Placental Abruption,Cleft Lip/Palate,Ophthalmia Neonatorum,Bacterial Conjunctivitis,Male Infertility,Neural Tube Defects, Folate-Sensitive,Rectal Disease,Disorders Of Intracellular Cobalamin Metabolism,Methotrexate Toxicity,Migraine With Aura,Megaloblastic Anemia,Urethritis,Urethral Syndrome,Cardia Cancer,Anus Disease,Homocysteinemia,Methylmalonic Acidemia,Homocystinuria-Megaloblastic Anemia, Cble Complementation Type,Neural Tube Defects,Orofacial Cleft,Vitamin Metabolic Disorder,Vitamin B12 Deficiency,Methylmalonic Aciduria And Homocystinuria Type Cble,Methylmalonic Aciduria And Homocystinuria Type Cblg,Down Syndrome,Autism Spectrum Disorder,Lipoprotein Quantitative Trait Locus,Anencephaly,Myelomeningocele,Chromosomal Duplication Syndrome,Marfan Syndrome,Phenylketonuria |
2qtl_a | Q9UBK8 | ENSG00000124275 | MTRR | 98.90 | 4.00E-13 | 3.20E-17 | 150.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YKL220C | FRE2 | SGDID:S000001703 | Sputcn32_0076 |
Sputcn32_0076 |
Shewanella putrefaciens | 2gpj_a | A4Y1H9 | 99.30 | 1.40E-16 | 1.20E-20 | 160.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | petH |
Ferredoxin--NADP reductase (FNR) (EC 1.18.1.2) |
1.18.1.2 | Nostoc sp. | 1qgz_a | P21890 | 99.60 | 2.30E-19 | 1.90E-23 | 185.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | nqrF PG_2177 |
nqrF PG_2177 |
7.2.1.1 | Porphyromonas gingivalis | 2r6h_b | Q7MT22 | 99.50 | 1.30E-18 | 1.10E-22 | 179.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Por |
NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4) |
1.6.2.4 | Rattus norvegicus | 1ja1_a | P00388 | 98.90 | 2.20E-13 | 1.80E-17 | 154.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | cysJ b2764 JW2734 |
Sulfite reductase [NADPH] flavoprotein alpha-component (SiR-FP) (EC 1.8.1.2) |
1.8.1.2 | Escherichia coli | 1ddg_a | P38038 | 99.10 | 1.10E-14 | 9.00E-19 | 155.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YKL220C | FRE2 | SGDID:S000001703 | fpr |
Flavodoxin/ferredoxin--NADP reductase (EC 1.18.1.2) (EC 1.19.1.1) (Ferredoxin (flavodoxin):NADP(+) oxidoreductase) (Ferredoxin--NADP reductase) (FNR) (Flavodoxin--NADP reductase) (FLDR) |
1.18.1.2,1.19.1.1, | Rhodobacter capsulatus | 2bgi_a | Q9L6V3 | 99.50 | 1.40E-18 | 1.20E-22 | 177.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Nitric oxide dioxygenase (EC 1.14.12.17) |
Nitric oxide dioxygenase (EC 1.14.12.17) |
Malassezia yamatoensis | 6o0a_a | A0A4V8H045 | 99.40 | 4.40E-17 | 3.70E-21 | 176.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | NCP1 CPR1 NCPR1 PRD1 YHR042W |
NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4) |
1.6.2.4 | Saccharomyces cerevisiae | 2bf4_a | P16603 | 99.00 | 2.80E-14 | 2.30E-18 | 164.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | BTH_I0211 |
BTH_I0211 |
1.18.1.2 | Burkholderia thailandensis | 4f7d_b | Q2T230 | 99.40 | 7.00E-18 | 6.00E-22 | 171.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | PFC_09030 |
PFC_09030 |
1.18.1.2 | Pyrococcus furiosus | 5vj7_b | I6TYZ3 | 99.40 | 4.10E-17 | 3.40E-21 | 167.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | petH SYNPCC7002_A0853 |
Ferredoxin--NADP reductase (FNR) (EC 1.18.1.2) |
1.18.1.2 | Synechococcus sp. | 2b5o_a | P31973 | 99.50 | 9.10E-19 | 7.50E-23 | 189.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | fpr PA3397 |
fpr PA3397 |
1.18.1.2 | Pseudomonas aeruginosa | 3crz_a | Q9HYK7 | 99.50 | 9.10E-19 | 7.80E-23 | 176.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | TM51_09581 |
TM51_09581 |
Thermobifida fusca | 4yhb_b | A0A0M3KL21 | 99.40 | 2.00E-17 | 1.70E-21 | 169.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | cyp102A1 cyp102 BG04_163 |
Bifunctional cytochrome P450/NADPH--P450 reductase (Cytochrome P450(BM-3)) (Cytochrome P450BM-3) (Fatty acid monooxygenase) (Flavocytochrome P450 BM3) [Includes: Cytochrome P450 102A1 (EC 1.14.14.1); NADPH--cytochrome P450 reductase (EC 1.6.2.4)] |
1.14.14.1,1.6.2.4, | Bacillus megaterium | 4dqk_a | P14779 | 99.20 | 2.30E-15 | 1.90E-19 | 161.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | Sfri_2392 |
Sfri_2392 |
Shewanella frigidimarina | 6geh_a | Q080S8 | 99.40 | 6.40E-17 | 5.40E-21 | 163.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YKL220C | FRE2 | SGDID:S000001703 | 542713 ZEAMMB73_Zm00001d034345 |
542713 ZEAMMB73_Zm00001d034345 |
1.18.1.2 | Zea mays | 5h5j_c | B4G043 | 99.60 | 1.10E-19 | 9.50E-24 | 189.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YKL220C | FRE2 | SGDID:S000001703 | fpr mvrA b3924 JW3895 |
Flavodoxin/ferredoxin--NADP reductase (EC 1.18.1.2) (EC 1.19.1.1) (Ferredoxin (flavodoxin):NADP(+) oxidoreductase) (Ferredoxin--NADP reductase) (FNR) (Flavodoxin--NADP reductase) (FLDR) (Methyl viologen resistance protein A) (dA1) |
1.18.1.2,1.19.1.1, | Escherichia coli | 1fdr_a | P28861 | 99.40 | 1.30E-17 | 1.10E-21 | 166.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YKL220C | FRE2 | SGDID:S000001703 | sudB PF1327 |
Sulfide dehydrogenase subunit beta (SuDH) (EC 1.8.1.19) (Ferredoxin:NADP oxidoreductase) (FNOR) (EC 1.18.1.2) |
1.18.1.2,1.8.1.19, | Pyrococcus furiosus | 5jca_s | Q8U194 | 99.50 | 4.50E-18 | 3.80E-22 | 174.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |